Store
World Market for Cardiac Markers (POC and Lab-Based), 2021-2026
Publication Date: March 24, 2022
Tags: Cardiovascular Disease, Diagnostic Instruments, Interventional Cardiology, Point-of-Care (POC) Testing
Pages: 55
SKU: 22-051
Cardiovascular diseases, including those affecting the heart and brain’s blood vessels, are the leading cause of death globally. With the incidence of cardiovascular disease rising sharply, the demand for cardiac markers is increasing, driving constant research and development for improved diagnostics.
Kalorama Information’s World Market for Cardiac Markers (POC and Lab-Based), 2021-2026 provides crucial insights into the current state and future trends of the cardiac marker market. The report covers why cardiac markers are in huge demand and are a constant subject of research for improvement. This report is indispensable for business planning, market strategy development, and staying informed about advancements in cardiac diagnostics.
Report Highlights:
- Market Overview:
- Cardiac biomarkers are critical substances released into the bloodstream when the heart is damaged or stressed.
- These biomarkers are essential for diagnosing and managing chronic heart failure, assessing treatment options, and monitoring patient progress.
- Significance of Cardiac Biomarkers:
- Used in acute care settings to diagnose cardiac events and in evaluating the risk of future cardiovascular events.
- Traditional markers include BNP, troponin, and myoglobin, while cholesterol tests are used for risk evaluation.
- New biomarkers like cardiac troponin, Galectin-3, Copeptin, ST2, and MR-proADM show promise for enhancing traditional diagnostic methods.
- Comprehensive Cardiac Risk Assessment:
- A multidisciplinary approach includes biomarkers such as troponins (cTnI and cTnT), BNP, NT-proBNP, GFAP, H-FABP, LDH isoenzymes, D-dimer, IMA, MPO, myoglobin, and sCD40L.
- Cardiac risk work-ups typically include a mix of lipids and inflammation markers like cholesterol, HDL, LDL, homocysteine, fibrinogen, C-reactive protein, lipoprotein fractions, and D-Dimer tests.
- Market Dynamics:
- An aging population and technological advancements are driving the growth of the cardiac marker market.
- Approximately 2.6 million people die of cardiovascular disease each year in the seven leading countries (France, Germany, Italy, Japan, Spain, UK, and the U.S.), concentrating the market in developed regions.
Table: Cardiac Marker Diagnostic Sales, by Test Type, 2021-2026 ($ millions)
| Type | 2021 | % Mkt | 2026 | % Mkt | CAGR |
| Lab-based Cardiac Markers | $XX Million | XX% | $XX Million | XX% | XX% |
| Point-of-Care Cardiac Markers | $XX Million | XX% | $XX Million | XX% | XX% |
| Total | $XX Million | XX% | $XX Million | XX% | XX% |
Source: Kalorama Information
For further details and to purchase directly, please contact us.
Table of Contents
CHAPTER 1: EXECUTIVE SUMMARY
OVERVIEW OF THE MARKET
MARKET SIZE AND GROWTH FORECAST
A CHANGING MENU
RECENT DEVELOPMENTS
- Ambulance Study
- COVID-19 and Cardiac Markers
- Notre Dame Team Developing Cardiac Biosensor
- Roche Gets Green Light for TGen5 Immunoassay
- Tosoh Gets Nod for 18 Minute BNP
- Siemens Healthineers AI-based COVID-19 Severity Algorithm
- Lower Limit Debate Continues
CHAPTER 2: MARKET ANALYSIS
-
- Table 2-1: Cardiac Marker Diagnostic Sales by Test Type, 2021-2026 (Lab-based, PoC-based) ($ millions)
-
- Figure 2-1: Cardiac Marker Testing Market by Segment ($M)
-
- Figure 2-2: Cardiac Marker Testing Market by Type and Total, Annual Change Over Time (% Change)
-
- Figure 2-3: Cardiac Marker Testing Market by Marker (% Share)
- Major Product Activity
- Troponin
- BNP
- Myoglobin/CK-MB
REGIONAL MARKET
-
- Table 2-2: Cardiac Marker Test Sales Distribution by Global Region, 2021 (North America, Europe, Asia Pacific, RoW)
VENDOR MARKET SHARE
-
- Figure 2-4: Leading Vendors in the Cardiac Marker Segment, 2021 Market Share
RAPID CARDIAC MARKERS
LAB-BASED CARDIAC MARKER MARKET
D-DIMER REVENUE AND GROWTH
CHAPTER 3: TOP COMPANY BRIEFS
ABBOTT DIAGNOSTICS
- i-STAT Business
BECKMAN COULTER, INC. / DANAHER
- Siemens Healthineers
SIEMENS HEALTHINEERS (SIEMENS)
QUIDEL CORPORATION
- The Alere Triage Business
- Immunoassays
- Rapid Immunoassays
RADIOMETER A/S / DANAHER
- Immunoassays
ROCHE DIAGNOSTICS
RESPONSE BIOMEDICAL CORP
- Company Overview
- Products
BIOTRON DIAGNOSTICS
- Products
BOSON BIOTECH CO.,
- Company Overview
- Products
NANO-DITECH CORPORATION
- Products
CTK BIOTECH, INC.
DIAZYME LABORATORIES, INC.
OPKO HEALTH, INC
TRINITY BIOTECH PLC
TOSOH BIOSCIENCE
Related products
COVID-19 Testing Markets, 2023
May 18, 2023
As the COVID-19 pandemic evolves into an endemic phase, the landscape of COVID-19 testing is changing rapidly. Kalorama Information’s COVID-19 Testing Markets, 2023 report provides crucial insights into this shifting market, answering key questions and providing valuable market sizing and estimates.
Key Insights Provided:
- Market impacts and trends in the evolving COVID-19 testing…
Price range: $4,000.00 through $6,000.00
IVD Market Trends Report, March 2023
March 17, 2023
Diagnostic testing remains a cornerstone in healthcare, aiding physicians in diagnosis and providing crucial information for treatments like precision medicine. As we navigate the aftermath of the COVID-19 pandemic, the IVD market is evolving, driven by new products, shifts in global health spending, regulatory updates, and changing disease trends. Despite these shifts, the IVD market…
Price range: $3,000.00 through $4,500.00
The Worldwide Market for Clinical Laboratory Services, 9th Edition
June 25, 2024
Understanding the clinical laboratory market is crucial for effective business planning. The Worldwide Market for Clinical Laboratory Services, 9th Edition answers essential questions such as the size of the service market for clinical testing, the types of tests that are in demand, and the future trajectory of this market 2023-2028. It also identifies the companies…
Price range: $5,000.00 through $7,500.00
